Ethical Considerations in Research

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:27 PM on 9/10/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

27 Terms

1
New cards

select all that apply:

what is the biopharmaceutical research and development process?

1. discovery / preclinical

2. clinical trials (humans)

3. FDA review

4. Post-marketing (phase IV)

2
New cards

select all that apply:

why are RCTs the gold standard?

1. chance decides who gets the new drug vs control

2. compares against placebo or best current therapy

3. reduces bias

3
New cards

preclinical → file IND → phases 1-3 → file NDA/BLA → ___________.

approval

4
New cards

historical example of misbranding/false medical claims. FDA's role is to protect the public by policing safety, efficacy, and truthful labeling.

crazy water crystals

5
New cards

select all that apply:

why do ethical dilemmas happen?

1. don't know the rules

2. practice vs. personal values

3. principles collide

4. conflicts of interest/greed

5. typical unethical behaviors

6
New cards

reasoned standards for right action; argued and justified (what we use in professional decision making).

ethics

7
New cards

personal/community rules often received from an authority or tradition.

morality

8
New cards

organized belief system that can shape a person's morality/values.

religion

9
New cards

personal priorities that evolve over time (e.g., current emphasis on patient autonomy vs. past paternalism).

values

10
New cards

select all that apply:

what are some issues in medical ethics for providers?

1. withholding treatment due to budgets/insurance

2. taking industry money, upcoding

3. romantic relationships with patients/families

4. covering up mistakes

5. reporting an impaired colleague

6. cherry-picking patients

7. prescribing/dispensing placebos

8. defensive medicine

9. dropping insurers

10. breaching confidentiality for a health risk

11
New cards

select all that apply:

who decides medical ethics?

1. professional codes and guidance

2. laws & regulations

3. institutional policies and ethics committees

4. case law & standards of care.

12
New cards

select all that apply:

what are the pharmacist-specific dilemmas?

1. religious convictions

2. medication safety concerns

3. two policies at odds

4. law vs ethics

13
New cards

select all that apply:

what do you do if you spot an ethical issue?

1. identify the issue

2. apply standards

3. generate options & assess harms/benefits

4. decide and document

5. review & reflect

14
New cards

select all that apply:

why do these ethics rules exist?

1. Tuskegee (1932-72)

2. Nuremberg Code (1947)

3. National Research Act & 45 CFR 46 (1974)

4. Belmont Report (1979)

15
New cards

select all that apply:

what are the three ethical principles?

1. respect for persons

2. beneficence

3. justice

16
New cards

people are agents with the right to make their own choices. in research, you honor that by getting informed consent and protecting privacy.

IRB review (non-human/exempt/expedited/full committee) checks that consent and protections are appropriate. consent must be voluntary, confidential, and understandable.

respect for persons

17
New cards

select all that apply:

what are the four components of informed consent?

1. capacity

2. disclosure

3. comprehension

4. voluntariness

18
New cards

select all that apply:

who are the populations that need extra safeguards and often additional approvals?

1. adults lacking capacity

2. children/teens

3. pregnant people/fetuses

4. prisoners

5. economically/educationally disadvantaged.

19
New cards

do no harm and maximize benefit vs. risk.

in practice

keep the risk/benefit ratio low.

use Data & Safety Monitoring plans/boards, stopping rules, and prompt reporting of adverse events.

if risk increases during a trial, pause or stop the study.

beneficence

20
New cards

fairness in who bears the burdens and who gains the benefits of research.

in practice

fair recruitment and access; avoid targeting or excluding groups without good reason.

use random selection when possible.

historical cautionary tale: Tuskegee Syphilis Study—an example of profound injustice to avoid repeating.

justice

21
New cards

select all that apply:

what does HIPAA cover?

1. PHI (Protected Health Information)

2. the 18 identifiers

22
New cards

select all that apply:

what are HIPAA's three areas of compliance?

1. administrative

2. physical

3. technical

23
New cards

policies, training, role-based access, incident response.

administrative

24
New cards

facility security, locked rooms, secure disposal of papers/devices.

physical

25
New cards

unique logins, encryption, firewalls, audit logs, automatic time-outs.

technical

26
New cards

select all that apply:

what are the key ethical challenges in clinical research?

1. placebo or not

2. phase I trials

3. conflicts of interest

4. quality improvement (QI) vs research

5. genetic testing & data use

6. public trial registries

7. globalization

8. practices vs society/individual values

27
New cards

select all that apply:

what are five issues pharmacists may face?

1. patient confidentiality (HIPAA)

2. patient relationships

3. malpractice/negligence

4. informed consent

5. dispense or not (conscience clauses)